GoodRx Holdings, Inc.
GDRX
$3.44
-$0.01-0.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.31% | -4.42% | -1.91% | 0.40% | 1.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.31% | -4.42% | -1.91% | 0.40% | 1.23% |
| Cost of Revenue | 57.30% | 50.82% | 43.23% | 14.85% | 12.47% |
| Gross Profit | -5.43% | -8.31% | -4.87% | -0.52% | 0.52% |
| SG&A Expenses | -5.69% | -1.72% | -5.21% | 0.05% | -6.44% |
| Depreciation & Amortization | 12.87% | 4.21% | 21.21% | 22.22% | 16.29% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.29% | 2.75% | -1.40% | 3.75% | -2.47% |
| Operating Income | -11.85% | -49.59% | -4.05% | -28.36% | 34.87% |
| Income Before Tax | -21.00% | -66.17% | 24.40% | -24.80% | 68.10% |
| Income Tax Expenses | 2.91% | -20.41% | 87.79% | 20.11% | 35.99% |
| Earnings from Continuing Operations | -33.54% | -89.42% | -19.51% | -71.78% | 91.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.54% | -89.42% | -19.51% | -71.78% | 91.86% |
| EBIT | -11.85% | -49.59% | -4.05% | -28.36% | 34.87% |
| EBITDA | -1.37% | -26.49% | 43.59% | -4.98% | 26.31% |
| EPS Basic | -30.00% | -88.32% | -10.17% | -69.23% | 102.25% |
| Normalized Basic EPS | -16.91% | -70.32% | 0.58% | -34.52% | 77.72% |
| EPS Diluted | -44.44% | -88.32% | -10.17% | -68.00% | 102.25% |
| Normalized Diluted EPS | -18.95% | -70.32% | 0.77% | -32.93% | 81.48% |
| Average Basic Shares Outstanding | -4.86% | -10.20% | -10.85% | -8.66% | -5.22% |
| Average Diluted Shares Outstanding | -2.55% | -10.07% | -11.16% | -10.47% | -7.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |